Phase I trial of temsirolimus (TEM), irinotecan (IRN), and temozolomide (TMZ) in children with refractory solid tumors: A Children's Oncology Group study.
Rochelle Bagatell
No relevant relationships to disclose
Robin Elizabeth Norris
No relevant relationships to disclose
Ashish M Ingle
No relevant relationships to disclose
Charlotte H Ahern
No relevant relationships to disclose
Jennifer Saggio
No relevant relationships to disclose
Anthony Little
No relevant relationships to disclose
Brenda Weigel
No relevant relationships to disclose
Susan Blaney
No relevant relationships to disclose